AI chatbot health use rises in Swiss survey

That matters economically because healthcare is one of the largest spending categories in developed economies, and AI is beginning to touch the front end of that system: triage, information gathering and patient engagement. If people increasingly treat chatbots as a first stop for symptoms, insurers, healthcare providers and medical technology companies will face a new layer of demand for digital tools that can handle volume at low cost while still keeping clinicians in the loop.

The study suggests AI is not replacing doctors so much as becoming an extra layer of consultation. Doctors, the internet and family or friends remain among the main information sources, which points to a hybrid model rather than a wholesale shift away from human care. That is important for investors because the biggest commercial winners may not be consumer AI apps alone, but healthcare platforms, insurers and enterprise software companies that can build compliant AI into existing workflows.

The opportunity is real, but so is the risk. People are already using chatbots for physical symptoms and, increasingly, mental-health-related questions. The share citing AI as a main source for physical symptoms rose to 28% from 18%, while use for psychological symptoms climbed to 16% from 11%. Nearly one in five users said they shared information with a chatbot that they had never told a real person. That raises obvious concerns about privacy, accuracy and liability — the same issues that show up in Microsoft’s and C3.ai’s regulatory filings, where both companies warn that AI errors or hallucinations could damage trust and trigger legal exposure.

For long-term investors, the message is not that AI health tools are a fad. It is that adoption is widening fast, and the companies best positioned to benefit will be those that can pair utility with trust. In healthcare, trust is the moat. The market should expect more regulation, more clinical oversight and more demand for AI systems that assist rather than replace professionals.

That makes the trend worth watching for years, not weeks. The winners are likely to be the firms that help patients get faster answers without compromising safety, and the losers will be companies that treat health AI as a gimmick instead of a regulated service.